The natriuretic effect of GLP-1R agonists along with the effects of these drugs on the conventional risk factors for DN (such as hyperglycemia, hypertension and obesity) may represent the most relevant mechanisms underlying their antialbuminuric effect (Figure 1b). Here, GLP1R is linked to obesity disorder.